C. difficile infection
and the effective way to combat it
with HospBiome and DiffBiome MTT capsules
info@MicroBiomeBank.com
+36 30 013 5000
MicroBiome Bank Ltd.
2 Brandon Road,
Braintree, Essex
England, CM7 2NL
MicroBiome Bank Kft.
1118 Budapest,
Ménesi út 104. II. ép. al.
with HospBiome and DiffBiome MTT capsules
This is the shortened version of our page on Clostridium difficile treatment. By using this summary and providing the necessary information, you can receive a treatment protocol and order the most effective treatment system currently available — all within 20 minutes. If you need detailed information, please click the button below.
Due to increasing antibiotic resistance and the need to restore microbiota balance, Microbiota Transfer Therapy (MTT) is now a leading approach for C. difficile treatment. In confirmed cases, therapy can begin immediately based on symptoms.
MicroBiome Bank's DiffBiome and HospBiome capsules provide effective treatment options for both home and hospital use. We offer professional guidance to ensure appropriate therapy selection and to help reduce hospital-based interventions.
Please note that MicroBiome Bank does not sell a product but facilitates the connection between donors and recipients by providing professional medical services. We handle donor recruitment, screening, fecal testing and the processing of the screened donation into capsule form through qualified laboratories. The contents of the capsules remain the property of the donor, subject to the cost of medical services, until fully paid by the recipient. The brand names of the individual services are intended solely to make them easier to remember and to simplify the ordering process.
The following steps are essential for using our DiffBiome and HospBiome services, which are designed to effectively treat Clostridium difficile infection and the underlying dysbiosis caused by antibiotic misuse.
Please get in touch with us by filling out the form located at the bottom of the page! In response, we will send you the most important information and register you as an interested party.
Contact usThe second step will be registration, which you can complete using the link sent to you by our system via email. Upon registration, you will receive an identifier in the format P0000000, which we will refer to in all future correspondence.
We will ask you to share your experience regarding your illness and previous treatments, as well as your expectations for FMT by completing a questionnaire.
As a next step, we will assess your current condition using the Symptom Importance Scale (SIS) and provide a recommendation for the appropriate treatment protocol. If any of our capsules may help improve your condition, we will grant you access by sending you the ordering link for the appropriate capsule.
The recommended capsules will be shipped to you via courier service within a maximum of 4 business days.
If your symptoms persist after 15 days, we offer the option of an online consultation to further personalize your treatment. Our exposome specialist will support you in overcoming dysbiosis through microbiome profiling that utilizes fluorocoding and optical mapping technology.
Microbiota Transfer Therapy (MTT) is currently the most effective method for treating recurrent Clostridioides difficile infection, capable of restoring natural functionality. When conducted according to professional guidelines and MTT regulations, the procedure is safe. The use of MTT reduces the likelihood of recurrent infections while also improving gut microbiota diversity as a beneficial side effect.
(In accordance with applicable regulations, the capsules are provided as a service under code 869015 — Medical Laboratory Services, as defined by SCPA 2008.)
The success of the treatment depends on the concentration of bacteria used and the duration of the therapy. The required dose and duration are determined based on a comprehensive evaluation system. This evaluation test is based on the Symptom Importance Scale (SIS), a structured clinical scoring system developed to assess the severity of Clostridioides difficile infections. The SIS integrates 24 key variables, including patient-reported symptoms, laboratory findings, treatment history, and known risk factors. The system synthesizes data from four validated clinical models: Zar Score, ATLAS, Hines VA Severity Score, and the CARDS (Clostridium difficile Associated Risk of Death Score).
MicroBiome Bank, when providing the HospBiome and DiffBiome services, neither verifies nor intends to verify the authenticity of the provided identity and/or medical prescription. By placing an order, the customer acknowledges that the laboratory will perform the ordered service under the name provided by the customer, using a donor sample assigned with a laboratory-tested code. The processing is unique, and the final HospBiome and DiffBiome capsules are identifiable and traceable through an assigned code. By ordering HospBiome and DiffBiome capsules, the customer declares that the capsules, labeled "For Physician Use," will be administered under the supervision of their treating physician. Any effects resulting from intentional or unintentional miscommunication or the provision of false information are solely the responsibility of the customer.
In the future, we will use the assigned registration number for any procedures performed for you. Please provide a brief explanation in the "Message" section at the bottom of the Contact Form, detailing what issue you are seeking help for, who referred you, and which healthcare professional is supporting your decision to use our services.